These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 620495)

  • 1. Skeletal blood flow in Paget's disease of bone and its response to calcitonin therapy.
    Wootton R; Reeve J; Spellacy E; Tellez-Yudilevich M
    Clin Sci Mol Med; 1978 Jan; 54(1):69-74. PubMed ID: 620495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of skeletal blood flow in Paget's disease with disodium etidronate therapy.
    Walton KR; Green JR; Reeve J; Wootton R
    Bone; 1985; 6(1):29-31. PubMed ID: 3922391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal blood flow in Paget's disease of bone.
    Wootton R; Tellez M; Green JR; Reeve J
    Metab Bone Dis Relat Res; 1981; 3(4-5):263-70. PubMed ID: 6762483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone.
    Shai F; Baker RK; Wallach S
    J Clin Invest; 1971 Sep; 50(9):1927-40. PubMed ID: 4935444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Calcitonin nasal spray for Paget's disease of the bone].
    Luboshitzky R; Bar-Shalom R
    Harefuah; 1995 Mar; 128(6):358-62, 399. PubMed ID: 7750816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remissions in Paget's disease produced by human synthetic calcitonin (calcitonin M).
    Woodhouse NJ; Reiner M; Kalu DN; Galante L; Joplin GF; MacIntyre I
    Clin Sci; 1970 Sep; 39(3):9P-10P. PubMed ID: 5459177
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Paget's disease of bone with porcine calcitonin.
    Eisman JA; Xipell JM; Sloman JG; Jerums G; Martin TJ
    Med J Aust; 1974 Apr; 1(15):564-8. PubMed ID: 4858264
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term treatment of Paget's disease of bone with salmon calcitonin.
    Sturtridge WC; Harrison JE; Wilson DR
    Can Med Assoc J; 1977 Nov; 117(9):1031-4. PubMed ID: 562231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal turnover and total body elemental composition during extended calcitonin treatment of Paget's disease.
    Wallach S; Avramides A; Flores A; Bellavia J; Cohn S
    Metabolism; 1975 Jun; 24(6):745-53. PubMed ID: 1128238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of skeletal blood flow in normal man and in patients with Paget's disease of bone.
    Wootton R; Reeve J; Veall N
    Calcif Tissue Res; 1976 Aug; 21 Suppl():380-5. PubMed ID: 782666
    [No Abstract]   [Full Text] [Related]  

  • 11. [Human calcitonin in the treatment of symptomatic Paget's disease].
    Mathä R; Kovarik J; Woloszczuk W; Plenk H; Willvonseder R; Böhler N; Seidl G; Höfer R
    Aktuelle Gerontol; 1983 Jan; 13(1):10-4. PubMed ID: 6131616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardiovascular system in Paget's disease of bone and the response to therapy with calcitonin and diphosphonate.
    Henley JW; Croxson RS; Ibbertson HK
    Aust N Z J Med; 1979 Aug; 9(4):390-7. PubMed ID: 292378
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?].
    Davoine GA; Jung A; Courvoisier B
    Schweiz Med Wochenschr; 1981 Apr; 111(15):518-24. PubMed ID: 6785879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paget's disease of the bone: observations after cessation of long-term synthetic salmon calcitonin treatment.
    Avramides A; Flores A; DeRose J; Wallach S
    J Clin Endocrinol Metab; 1976 Mar; 42(3):459-63. PubMed ID: 1254686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the treatment of the osteodystrophia deformans (Paget's disease) with synthetic salmon calcitonin (author's transl)].
    Trzenschik K; Schmidt UJ; Abendroth K; Ansorg H; Graner H; Lindenhayn K; Schramm G; Kalbe I
    Z Alternsforsch; 1978; 33(5):441-51. PubMed ID: 570764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human calcitonin in the treatment of Paget's bone disease.
    Woodhouse NJ; Bordier P; Fisher M; Joplin GF; Reiner M; Kalu DN; Foster GV; MacIntyre I
    Lancet; 1971 Jun; 1(7710):1139-43. PubMed ID: 4102856
    [No Abstract]   [Full Text] [Related]  

  • 17. Paget's disease of bone (osteitis deformans) treated with human synthetic calcitonin.
    Epstein S; Owen G
    S Afr Med J; 1977 Jan; 51(5):133-7. PubMed ID: 850845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical markers of bone turnover in Paget's disease.
    Russell RG; Beard DJ; Cameron EC; Douglas DL; Forrest AR; Guilland-Cumming D; Paterson AD; Poser J; Preston CJ; Milford-Ward A; Woodhead S; Kanis JA
    Metab Bone Dis Relat Res; 1981; 3(4-5):255-62. PubMed ID: 6220191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paget's bone disease treated with diphosphonate and calcitonin.
    Hosking DJ; Bijvoet OL; van Aken J; Will EJ
    Lancet; 1976 Mar; 1(7960):615-7. PubMed ID: 55896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of Paget's disease of bone with salmon calcitonin (author's transl)].
    Kuhlencordt F; Ringe JD; Kruse HP
    Dtsch Med Wochenschr; 1981 Nov; 106(48):1620-3. PubMed ID: 7308002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.